Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.13 Insider Own12.74% Shs Outstand14.32M Perf Week-3.26%
Market Cap42.53M Forward P/E- EPS next Y-0.46 Insider Trans0.00% Shs Float12.50M Perf Month-5.71%
Income-6.89M PEG- EPS next Q-0.12 Inst Own6.65% Short Float1.65% Perf Quarter-25.75%
Sales0.34M P/S125.09 EPS this Y55.45% Inst Trans8.21% Short Ratio0.76 Perf Half Y133.86%
Book/sh0.53 P/B5.64 EPS next Y-1.11% ROA-95.89% Short Interest0.21M Perf Year324.29%
Cash/sh0.33 P/C8.88 EPS next 5Y- ROE-101.53% 52W Range0.70 - 6.85 Perf YTD137.60%
Dividend Est.- P/FCF- EPS past 5Y18.43% ROI-103.76% 52W High-56.64% Beta1.02
Dividend TTM- Quick Ratio66.29 Sales past 5Y9.26% Gross Margin42.24% 52W Low324.29% ATR (14)0.37
Dividend Ex-Date- Current Ratio66.29 EPS Y/Y TTM6.34% Oper. Margin-2024.38% RSI (14)43.03 Volatility10.22% 12.07%
Employees5 Debt/Eq0.02 Sales Y/Y TTM94.44% Profit Margin-2022.66% Recom1.00 Target Price10.00
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q79.57% Payout- Rel Volume0.60 Prev Close2.93
Sales Surprise- EPS Surprise40.00% Sales Q/Q42.89% EarningsApr 09 Avg Volume270.85K Price2.97
SMA20-11.34% SMA50-1.40% SMA20040.34% Trades Volume171,420 Change1.37%
Jun-18-24 09:00AM
Jun-14-24 07:15AM
Jun-05-24 09:00AM
Jun-04-24 07:28AM
May-30-24 06:45AM
09:05AM Loading…
May-23-24 09:05AM
May-21-24 09:20AM
May-17-24 09:10AM
May-08-24 09:10AM
May-06-24 09:05AM
Apr-30-24 03:40PM
Apr-16-24 09:10AM
Apr-09-24 09:52PM
Apr-02-24 09:00AM
Mar-21-24 09:20AM
09:20AM Loading…
Mar-14-24 09:20AM
Mar-07-24 09:05AM
Mar-05-24 09:05AM
Mar-04-24 09:15AM
Mar-01-24 08:20AM
Feb-16-24 04:05PM
Feb-15-24 08:00AM
Jan-30-24 08:45AM
Jan-24-24 08:45AM
Jan-22-24 08:51AM
Jan-16-24 09:10AM
Jan-11-24 08:30AM
Jan-10-24 08:30AM
Jan-09-24 08:30AM
Jan-08-24 08:30AM
09:05AM Loading…
Jan-04-24 09:05AM
Dec-07-23 09:20AM
Nov-28-23 09:10AM
Nov-27-23 09:05AM
Nov-01-23 08:30AM
Oct-31-23 08:31AM
Oct-30-23 09:30AM
Oct-13-23 09:05AM
Oct-12-23 09:10AM
Sep-29-23 08:00AM
Sep-21-23 09:10AM
Aug-30-23 09:20AM
Aug-28-23 09:02AM
Aug-23-23 11:12AM
Aug-09-23 09:15AM
Aug-02-23 09:10AM
Jul-28-23 09:10AM
Jul-19-23 09:05AM
Jun-26-23 07:47AM
Jun-22-23 09:25AM
Jun-20-23 09:05AM
Jun-16-23 09:10AM
Jun-12-23 09:20AM
May-23-23 09:05AM
May-18-23 04:22PM
May-11-23 01:45PM
May-10-23 10:15AM
May-08-23 08:35PM
Apr-24-23 09:00AM
Apr-20-23 09:00AM
Mar-07-23 05:54AM
Mar-02-23 08:45AM
Feb-21-23 02:41PM
Jan-31-23 08:30AM
Jan-23-23 08:45AM
Jan-17-23 08:33AM
Jan-13-23 04:05PM
Dec-29-22 09:00AM
Dec-21-22 09:00AM
Dec-20-22 12:35PM
Nov-30-22 05:24AM
Nov-29-22 08:50AM
Nov-21-22 09:19AM
Nov-10-22 09:20AM
Nov-08-22 09:10AM
Nov-01-22 09:25AM
Oct-31-22 05:26AM
Oct-27-22 08:45AM
Sep-20-22 08:30AM
Sep-02-22 09:15AM
Aug-31-22 09:05AM
Aug-11-22 09:15AM
Aug-10-22 10:36AM
Aug-09-22 08:30AM
Aug-03-22 09:45AM
Jul-27-22 09:10AM
Jul-26-22 09:05AM
Jul-14-22 09:10AM
Jul-13-22 09:05AM
Jul-07-22 09:05AM
Jun-21-22 09:00AM
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. Its products can be used with APIs fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) pain medications, hormones, phosphodiesterase inhibitors, antivirals, nicotine and its analogs, and all cannabinoids including tetrahydrocannabinol (THC) for therapeutic indications, as well as hypertension, SARS-CoV-2/COVID-19, and HIV/AIDS. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carle VanessaSecretaryMay 14 '24Option Exercise1.152,5002,8752,567May 15 05:37 PM